newsfilter
← Latest News
PR Newswire·

Tetra Bio-Pharma Receives Positive Scientific Advice Assessment (SAA) Report for QIXLEEF™

SAA Report endorsed Tetra Bio-Pharma's proposed nonclinical development and quality programs for QIXLEEF™. SAA Report provides clarity on clinical requirements for registration in Europe. OTTAWA, ON, Sept. 2, 2021 /PRNewswire/ - Tetra Bio-Pharm